GenApps

GenApps is a biotechnology company dedicated to developing a programmable gene therapy platform designed to overcome the limitations of traditional viral vectors. The company's proprietary "GenApp" technology utilizes synthetic DNA constructs and non-viral delivery mechanisms to provide precise, redosable, and scalable genetic medicines. By focusing on modularity and safety, GenApps aims to expand the reach of gene therapy to a broader range of indications, including chronic and complex diseases. The company's approach emphasizes the creation of "programmable" medicines that can be tailored for specific tissue targeting and expression levels. Currently in the pre-clinical stage, GenApps is optimizing its delivery systems and advancing its internal pipeline of therapeutic candidates.